BURLINGAME, Calif.--(Business enterprise WIRE)--Humanigen, Inc. (Nasdaq:HGEN) (“Humanigen”), a scientific-stage biopharmaceutical corporation concentrated on protecting against and treating an immune hyper-response...
BURLINGAME, Calif.--(Business enterprise WIRE)--Humanigen, Inc. (Nasdaq:HGEN) (“Humanigen”), a scientific-stage biopharmaceutical corporation concentrated on protecting against and treating an immune hyper-response...